Ccc Intelligent Solutions Hld Stock Price, News & Analysis

Clarivate Plc (NYSE:CCC) released the 2020 CMR International Pharmaceutical Clinical Factbook, highlighting significant trends in the Phase II clinical trials. The report shows a 7% increase in clinical trial volume from 2014 to 2019, with Phase II trials having 85% amendments. Notably, the average cost per Phase II trial subject exceeds US$90,000, marking these trials as the most expensive. The findings also indicate that while Asia Pacific and North America initiated similar numbers of trials, patient recruitment predominantly occurs in North America.

Clarivate Plc (NYSE: CCC) announced that its subsidiary, MarkMonitor Information Technology, is now a licensed domain name registrar in Mainland China. This enables MarkMonitor to offer multiple top-level domains (TLDs) like .com and .net, facilitating companies' entry into the significant Chinese online market. With over one billion internet users, this expansion supports Clarivate's mission to enhance its intellectual property solutions in a rapidly growing region. The initiative aims to help companies manage domain portfolios while mitigating security risks associated with domain management.

Clarivate Plc (NYSE:CCC) releases its 2020 Highly Cited Researchers list, recognizing 6,167 influential researchers globally. The US leads with 2,650 researchers (41.5%), although its share has decreased from 44% in 2019. Mainland China increases its representation to 770 researchers (12.1%), boosted by institutions like Tsinghua University. The list also features 26 Nobel laureates and 66 Citation Laureates. Notably, Europe and Australia show growth in their contributions to highly cited research, indicating a shift in global research dynamics.

On November 12, 2020, Clarivate Plc (NYSE: CCC) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. The presentation is scheduled for November 17, 2020, at 3:20 PM Eastern Time. A live webcast will be available on the Investor Relations section of the Clarivate website and a replay will be accessible for 30 days post-event. Clarivate is dedicated to providing trusted information and insights to accelerate innovation.

Clarivate Plc has unveiled its latest report analyzing the research performance of G20 nations, highlighting their contributions to COVID-19 research. The report, The Annual G20 Scorecard – Research Performance 2020, emphasizes that G20 countries produce 81% of global GDP and represent 92% of global R&D spending. It notes a surge in research output in member nations like Australia and China, contrasting with a decline in the United States. The findings aim to assist policymakers and researchers in tracking progress as the G20 prepares for its upcoming summit in Riyadh.

Clarivate Plc has announced the acquisition of Techstreet by the International Society of Interdisciplinary Engineers LLC (ISIE), a newly formed for-profit subsidiary of the American Society of Mechanical Engineers (ASME). This strategic move aims to enhance the $1.5B standards ecosystem, projected to reach $1.6B by 2023. With Techstreet joining ASME, the partnership intends to leverage their combined expertise to innovate products and services for the engineering community, fostering further reputation and growth for Techstreet.

On November 2, 2020, Clarivate Plc (NYSE:CCC) announced a partnership with Techtrials Pesquisa e Tecnologia Ltda to expand its real-world data (RWD) offerings in Brazil, targeting 80% of the population. This three-year collaboration will allow customers to access the largest integrated RWD database in Brazil, encompassing over 195 million patients. The partnership aims to support various healthcare inquiries, including epidemiological and clinical outcomes, and is expected to enhance decision-making for life science companies given Brazil's growing pharmaceutical market.

Clarivate Plc (NYSE: CCC) announced the resignation of Michael S. Klein from its Board of Directors, effective immediately. Klein was a pivotal figure, having previously served as Chairman of Churchill Capital Corp, which merged with Clarivate in May 2019. Jerre Stead, CEO and Executive Chairman, expressed gratitude for Klein's contributions over the past years. Following his departure, the board will consist of 12 members. Clarivate continues to lead in providing innovative solutions to enhance the lifecycle of innovation, aiding clients in scientific and healthcare fields.

Clarivate Plc (NYSE:CCC) has launched the enhanced EndNote 20, a reference management tool aimed at improving the efficiency of researchers and students in managing bibliographies. The new version features a modern user interface, better search capabilities, and PDF editing functionalities. Enhanced collaboration is facilitated through integration with the Web of Science, allowing users to access citation metrics directly in EndNote. With support for over 7,000 bibliographic styles, EndNote 20 aims to streamline research workflows and reduce time spent on formatting.